About the Program: Join us for our January ALS Learning series with Dr. Paul Mehta to learn how the National ALS Registry helps advance research. Dr. Mehta will discuss how to join the National ALS Registry, what information they collect and why, and the type of research the registry is conducting. A Q&A session will follow the discussion.
ALS research depends on people living with ALS to join the National ALS Registry. Every individual’s story can contribute to our understanding of the disease, its causes, and how to fight it.
The Les Turner ALS Foundation is proud to offer this webinar at no cost to the ALS community. Thank you to Mitsubishi Tanabe Pharma America for sponsoring this webinar.
About the Speaker,
Paul Mehta, MD, Principal Investigator
National ALS Registry
Centers for Disease Control and Prevention
Dr. Mehta is the Principal Investigator for the US Congressionally-Mandated National Amyotrophic Lateral Sclerosis (ALS) Registry which is part of the Centers for Disease Control and Prevention (CDC). Since 2013, Dr. Mehta has been responsible for providing medical, scientific, and epidemiological expertise on matters related to ALS. Prior to joining ATSDR, Dr. Mehta was responsible for overseeing external research initiatives for the National Center for Environmental Health (NCEH) and ATSDR. Dr. Mehta started his career at CDC as a Team Leader for the Division of Select Agents and Toxins (DSAT) where he was responsible for CDC’s Etiological Agent Import Permit Program (EAIPP) as well as conducting audits of high containment laboratories nationally. Dr. Mehta has a Doctor of Medicine (MD) from Fatima Medical Science Foundation and Bachelor of Arts in Biology from the University of Toledo.